Published in AIDS Weekly, October 9th, 1995
Richard O'Brien of WHO's Global TB Program said this is certainly the case with regard to HIV positive persons in developing countries with dual infection.
"Giving life-long isoniazid preventive therapy just makes sense," O'Brien said in a presentation delivered at The Lancet Conference 1995, "The Challenge of Tuberculosis," held in Washington D.C., September 14 and 15.
"I'm not sure this requires a clinical study. It seems to me to be fairly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.